{"gene":"SSH1","run_date":"2026-06-10T07:46:41","timeline":{"discoveries":[{"year":2013,"finding":"PKD1 phosphorylates and inhibits SSH1L (SSH1) downstream of RhoA/PLCε signaling in cardiomyocytes. SSH1L inhibition prevents cofilin 2 translocation to mitochondria and blocks Bax mitochondrial translocation, thereby promoting cell survival after oxidative stress/ischemia-reperfusion injury.","method":"Genetic knockdown (SSH1L siRNA), pharmacological manipulation, western blotting for cofilin phosphorylation, mitochondrial fractionation, cardiomyocyte survival assays; epistasis established RhoA→PLCε→PKD1→SSH1L→cofilin2 pathway","journal":"Science signaling","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (knockdown, overexpression, genetic deletion of upstream components, fractionation, survival assay), pathway epistasis established across multiple papers and contexts","pmids":["24345679"],"is_preprint":false},{"year":2014,"finding":"SSH1 directly interacts with NOD1 at F-actin-rich sites and is an essential component of the NOD1 innate immune signaling pathway; SSH1-mediated cofilin activation is required for NOD1-dependent NF-κB activation and cytokine release. Cytochalasin D (actin polymerization inhibitor) rescued NOD1 signaling loss upon SSH1 depletion.","method":"Genome-wide siRNA screen, co-immunoprecipitation/interaction assay showing NOD1-SSH1 interaction at F-actin sites, NF-κB reporter assay, cytokine measurement, chemical rescue with cytochalasin D","journal":"PLoS pathogens","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal interaction shown, genome-wide screen validated with functional follow-up (NF-κB, cytokine, chemical rescue), single lab but multiple orthogonal methods","pmids":["25187968"],"is_preprint":false},{"year":2015,"finding":"SSH1 (SSH1L) acts as a cofilin-1 phosphatase in pancreatic cancer cells; SSH1L knockdown increased cofilin-1 Ser3 phosphorylation (inactivation) and inhibited cell migration without affecting proliferation. Cytochalasin D abrogated migration independently of SSH1L expression.","method":"siRNA-mediated knockdown of SSH1L in PC cell lines, western blotting for phospho-cofilin-1 (Ser3), wound-healing/migration assays, cytochalasin D rescue","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KD with phosphorylation readout and functional migration phenotype, single lab","pmids":["25684665"],"is_preprint":false},{"year":2004,"finding":"Missense mutation p.Ser63Asn and frameshift mutations in SSH1 were identified in families with disseminated superficial actinic porokeratosis (DSAP), implicating SSH1 phosphatase function in epidermal cytoskeleton organization.","method":"Genome-wide linkage analysis, candidate gene sequencing, mutation identification in affected families","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — genetic mutations in human families establish functional relevance, but no direct biochemical characterization of mutant activity","pmids":["15459975"],"is_preprint":false},{"year":2019,"finding":"In zebrafish cardiomyocytes, the mechanosensitive protein vinculin (VCL) recruits SSH1 and its effector cofilin (CFL) to regulate F-actin rearrangement and promote myofilament maturation in response to mechanical forces from heartbeat contraction.","method":"VCL interactome by mass spectrometry in contracting vs. non-contracting cardiomyocytes, co-immunoprecipitation, loss-of-function studies, live imaging of F-actin; genetic epistasis (VCL→SSH1→CFL)","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — interactome MS plus reciprocal Co-IP, genetic epistasis, functional readout (myofilament maturation), multiple orthogonal methods","pmids":["31495694"],"is_preprint":false},{"year":2018,"finding":"PKCδ activates SSH1 in macrophages, which dephosphorylates cofilin at Ser3, leading to membrane ruffle formation and macropinocytosis. SSH1 silencing blocked cofilin dephosphorylation and inhibited macropinocytosis stimulated by phorbol ester or HGF.","method":"siRNA knockdown of SSH1, western blot for phospho-cofilin, scanning electron microscopy of ruffles, flow cytometry (FITC-dextran internalization), pharmacological inhibitors","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KD with phosphorylation readout and two functional assays (EM, flow cytometry), single lab","pmids":["30261270"],"is_preprint":false},{"year":2020,"finding":"SSH1 dephosphorylates phospho-Ser403-SQSTM1/p62, thereby impairing SQSTM1 autophagic flux and reducing clearance of phospho-MAPT/tau. This action is fully dependent on SQSTM1 Ser403 phosphorylation status and is mechanistically separable from SSH1-mediated cofilin dephosphorylation.","method":"RNAi knockdown and overexpression of SSH1, genetically encoded fluorescent reporters, defined phospho-site mutant constructs, western blotting, proximity ligation assay, experiments in cell lines, primary neurons, and mouse brains","journal":"Autophagy","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods (KD, OE, mutant constructs, PLA, in vivo), direct phosphorylation readout, functional separation from cofilin activity, validated in neurons and brain","pmids":["33044112"],"is_preprint":false},{"year":2020,"finding":"NRP2 activates SSH1 in endothelial cells, which in turn activates cofilin to promote F-actin polymerization, HUVEC migration, and PNET angiogenesis via a VEGF/VEGFR2-independent pathway. SSH1 silencing blocked NRP2-induced cofilin activation and cell migration.","method":"siRNA knockdown of SSH1, western blot for cofilin phosphorylation, F-actin staining, wound-healing/tube formation assays, in vivo mouse PNET model","journal":"Cell & bioscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KD with phosphorylation readout and multiple functional assays, single lab","pmids":["32983407"],"is_preprint":false},{"year":2023,"finding":"SSH1 promotes intrahepatic cholangiocarcinoma (iCCA) cell proliferation, migration, and invasion through activation of the p38 MAPK pathway and enhanced expression of CXCL8.","method":"SSH1 overexpression and knockdown in iCCA cell lines, western blotting for p38 MAPK pathway components, CXCL8 measurement, proliferation/migration/invasion assays","journal":"Carcinogenesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain- and loss-of-function with pathway readout, single lab, limited mechanistic detail in abstract","pmids":["36857607"],"is_preprint":false},{"year":2023,"finding":"CRISPR-mediated SSH1 knockout or pharmacological inhibition suppressed HCC cell viability, migration, and invasion, and downregulated WNT/β-catenin pathway components (WNT3, β-catenin, LRP5/6) and circadian clock regulators (CLOCK, BMAL1), while upregulating CFL-1/2 and CRY1.","method":"CRISPR SSH1 knockout, pharmacological inhibition (Sennoside A), cell viability/migration/invasion assays, western blotting, in vivo mouse tumor model","journal":"Aging","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — CRISPR KO with multiple functional and pathway readouts, in vivo validation, single lab","pmids":["37837551"],"is_preprint":false},{"year":2024,"finding":"SSH1 modulates neuropathic pain and neuronal health in the medial prefrontal cortex by dephosphorylating cofilin and LIMK1; co-immunoprecipitation demonstrated interaction between SSH1 and LIMK1.","method":"Lentiviral overexpression and knockdown of SSH1 in mouse mPFC, behavioral assays, western blotting for p-cofilin and p-LIMK1, co-immunoprecipitation, immunofluorescence","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo gain/loss-of-function with phosphorylation and behavioral readouts plus Co-IP interaction, single lab","pmids":["39701356"],"is_preprint":false},{"year":2025,"finding":"RBMS1 promotes glioma cell proliferation through a c-Myc-SSH1 axis: RBMS1 induces c-Myc binding to SSH1 promoters, increasing SSH1 expression, which in turn supports proliferative behavior.","method":"Patient datasets, glioma cell lines, mouse xenograft models, chromatin immunoprecipitation (c-Myc binding to SSH1 promoter), knockdown/overexpression experiments, proliferation assays","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — transcriptional regulation mechanism established by ChIP and functional assays, single lab","pmids":["40120347"],"is_preprint":false}],"current_model":"SSH1 (Slingshot Homolog 1) is a protein phosphatase that canonically dephosphorylates and reactivates cofilin (Ser3) to promote actin dynamics and cell migration, but also dephosphorylates SQSTM1/p62 at Ser403 (independently of cofilin) to impair autophagic cargo clearance including phospho-tau; it is regulated by upstream kinases (PKD1 phosphorylates and inhibits it; PKCδ activates it), physically interacts with NOD1 at actin-rich sites to mediate innate immune NF-κB signaling, and is recruited by vinculin downstream of mechanical forces to coordinate myofilament maturation via the VCL-SSH1-CFL axis."},"narrative":{"mechanistic_narrative":"SSH1 (Slingshot Homolog 1) is a protein phosphatase that governs actin cytoskeletal dynamics by dephosphorylating cofilin at Ser3, reactivating it to drive F-actin remodeling across diverse cell types and physiological processes including cell migration, macropinocytosis, angiogenesis, and myofilament maturation [PMID:25684665, PMID:30261270, PMID:32983407]. Its cofilin-directed activity is embedded in defined signaling axes: it is activated downstream of PKCδ in macrophages to drive membrane ruffling and macropinocytosis [PMID:30261270] and downstream of NRP2 in endothelial cells to promote migration and angiogenesis [PMID:32983407], whereas PKD1 phosphorylates and inhibits SSH1 downstream of RhoA/PLCε, an event that controls cofilin-2 and Bax mitochondrial translocation and thereby cardiomyocyte survival [PMID:24345679]. SSH1 also operates within mechanotransduction, where vinculin recruits SSH1 and cofilin to remodel F-actin and promote myofilament maturation in response to contractile force [PMID:31495694], and it acts as an essential component of NOD1 innate immune signaling, interacting directly with NOD1 at F-actin-rich sites to enable NF-κB activation and cytokine release [PMID:25187968]. Beyond cofilin, SSH1 dephosphorylates SQSTM1/p62 at Ser403 in a manner mechanistically separable from its cofilin activity, impairing autophagic flux and reducing clearance of phospho-tau in neurons and brain [PMID:33044112]. SSH1 also dephosphorylates LIMK1 and modulates neuropathic pain in the prefrontal cortex [PMID:39701356], and it is co-opted in multiple cancers — supporting proliferation and invasion via p38 MAPK/CXCL8, WNT/β-catenin, and a c-Myc transcriptional axis [PMID:36857607, PMID:37837551, PMID:40120347]. Mutations in SSH1 are linked to disseminated superficial actinic porokeratosis, connecting its phosphatase function to epidermal cytoskeletal organization [PMID:15459975].","teleology":[{"year":2004,"claim":"Established the first human disease link for SSH1, indicating its phosphatase function is relevant to epidermal cytoskeletal integrity in vivo.","evidence":"Linkage analysis and candidate gene sequencing identifying missense and frameshift mutations in DSAP families","pmids":["15459975"],"confidence":"Medium","gaps":["No biochemical characterization of mutant phosphatase activity","Mechanism connecting loss of SSH1 to porokeratosis pathology not defined"]},{"year":2013,"claim":"Defined an upstream inhibitory regulator of SSH1, showing that PKD1 phosphorylation suppresses SSH1 to control cofilin-2/Bax mitochondrial translocation and cell survival.","evidence":"siRNA knockdown, pharmacology, mitochondrial fractionation and survival assays in cardiomyocytes establishing RhoA→PLCε→PKD1→SSH1→cofilin2 epistasis","pmids":["24345679"],"confidence":"High","gaps":["Direct phosphatase activity on the mitochondrial pool not biochemically reconstituted","How cofilin-2 translocation triggers Bax import is unresolved"]},{"year":2014,"claim":"Revealed a non-canonical role for SSH1 in innate immunity, placing its actin-regulatory activity upstream of NOD1-dependent NF-κB signaling.","evidence":"Genome-wide siRNA screen, NOD1-SSH1 Co-IP at F-actin sites, NF-κB reporter, cytokine measurement, and cytochalasin D rescue","pmids":["25187968"],"confidence":"High","gaps":["Whether SSH1 phosphatase activity is required versus a scaffolding role not fully separated","Direct binding interface with NOD1 not mapped"]},{"year":2015,"claim":"Confirmed SSH1 as a cofilin-1 Ser3 phosphatase driving cancer cell migration independently of proliferation.","evidence":"siRNA knockdown, phospho-cofilin western blot, wound-healing assays and cytochalasin D rescue in pancreatic cancer cells","pmids":["25684665"],"confidence":"Medium","gaps":["Single cancer context","Upstream activators in this setting not identified"]},{"year":2018,"claim":"Identified PKCδ as an activating upstream kinase coupling SSH1/cofilin activity to membrane ruffling and macropinocytosis.","evidence":"siRNA knockdown, phospho-cofilin western blot, scanning EM of ruffles, and FITC-dextran flow cytometry in macrophages","pmids":["30261270"],"confidence":"Medium","gaps":["Whether PKCδ acts directly on SSH1 not biochemically shown","Single lab"]},{"year":2019,"claim":"Positioned SSH1 within mechanotransduction, showing vinculin recruits it to convert contractile force into actin remodeling during myofilament maturation.","evidence":"VCL interactome MS in contracting vs non-contracting cardiomyocytes, reciprocal Co-IP, loss-of-function and live F-actin imaging with VCL→SSH1→CFL epistasis in zebrafish","pmids":["31495694"],"confidence":"High","gaps":["Direct VCL-SSH1 binding interface not mapped","How force modulates SSH1 catalytic activity unknown"]},{"year":2020,"claim":"Established a cofilin-independent substrate, showing SSH1 dephosphorylates SQSTM1/p62 Ser403 to impair autophagy and phospho-tau clearance.","evidence":"RNAi/overexpression, phospho-site mutant constructs, proximity ligation assay, and validation in cell lines, primary neurons and mouse brain","pmids":["33044112"],"confidence":"High","gaps":["Structural basis for substrate selection between p62 and cofilin not defined","Regulation of SSH1 activity toward p62 in neurodegeneration unresolved"]},{"year":2020,"claim":"Added NRP2 as an activator of SSH1 driving VEGF/VEGFR2-independent endothelial migration and tumor angiogenesis.","evidence":"siRNA knockdown, phospho-cofilin western blot, F-actin staining, tube formation assays and in vivo PNET model","pmids":["32983407"],"confidence":"Medium","gaps":["Direct NRP2-SSH1 coupling mechanism not shown","Single lab"]},{"year":2023,"claim":"Extended SSH1's pro-tumorigenic role to additional cancers via distinct downstream pathways (p38 MAPK/CXCL8 and WNT/β-catenin plus circadian regulators).","evidence":"Gain/loss-of-function with pathway western blots, CRISPR knockout, pharmacological inhibition, and in vivo tumor models in iCCA and HCC","pmids":["36857607","37837551"],"confidence":"Medium","gaps":["Whether phosphatase catalytic activity links SSH1 to these pathways not established","Connection to canonical cofilin axis in these contexts unclear"]},{"year":2024,"claim":"Showed SSH1 acts on LIMK1 in addition to cofilin in the prefrontal cortex to modulate neuropathic pain and neuronal health.","evidence":"Lentiviral overexpression/knockdown in mouse mPFC, behavioral assays, phospho-cofilin/phospho-LIMK1 western blots and SSH1-LIMK1 Co-IP","pmids":["39701356"],"confidence":"Medium","gaps":["Direct dephosphorylation of LIMK1 versus indirect effect not resolved","Single lab"]},{"year":2025,"claim":"Defined transcriptional control of SSH1, showing an RBMS1/c-Myc axis drives SSH1 expression to support glioma proliferation.","evidence":"ChIP for c-Myc binding to the SSH1 promoter, knockdown/overexpression, proliferation assays and xenografts","pmids":["40120347"],"confidence":"Medium","gaps":["Downstream SSH1 effector in glioma not defined","Single lab"]},{"year":null,"claim":"How SSH1 selects between its substrates (cofilin, SQSTM1/p62, LIMK1) and how distinct upstream inputs are integrated to direct context-specific outputs remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of substrate recognition","Mechanism integrating activating (PKCδ, NRP2) and inhibitory (PKD1) inputs unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[2,5,6]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[2,5,6,10]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[1,4]}],"localization":[{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[1,4]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[6]}],"pathway":[{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[6]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[1]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,5,7]}],"complexes":[],"partners":["CFL1","NOD1","VCL","LIMK1","PKD1","PRKCD","NRP2","SQSTM1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q8WYL5","full_name":"Protein phosphatase Slingshot homolog 1","aliases":["SSH-like protein 1","SSH-1L","hSSH-1L"],"length_aa":1049,"mass_kda":115.5,"function":"Protein phosphatase which regulates actin filament dynamics. Dephosphorylates and activates the actin binding/depolymerizing factor cofilin, which subsequently binds to actin filaments and stimulates their disassembly. Inhibitory phosphorylation of cofilin is mediated by LIMK1, which may also be dephosphorylated and inactivated by this protein","subcellular_location":"Cytoplasm, cytoskeleton; Cell projection, lamellipodium; Cleavage furrow; Midbody","url":"https://www.uniprot.org/uniprotkb/Q8WYL5/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SSH1","classification":"Not Classified","n_dependent_lines":29,"n_total_lines":1208,"dependency_fraction":0.024006622516556293},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SSH1","total_profiled":1310},"omim":[{"mim_id":"616063","title":"POROKERATOSIS 8, DISSEMINATED SUPERFICIAL ACTINIC TYPE; POROK8","url":"https://www.omim.org/entry/616063"},{"mim_id":"606780","title":"SLINGSHOT PROTEIN PHOSPHATASE 3; SSH3","url":"https://www.omim.org/entry/606780"},{"mim_id":"606779","title":"SLINGSHOT PROTEIN PHOSPHATASE 2; SSH2","url":"https://www.omim.org/entry/606779"},{"mim_id":"606778","title":"SLINGSHOT PROTEIN PHOSPHATASE 1; SSH1","url":"https://www.omim.org/entry/606778"},{"mim_id":"605435","title":"PROTEIN KINASE D1; PRKD1","url":"https://www.omim.org/entry/605435"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Uncertain","locations":[{"location":"Plasma membrane","reliability":"Uncertain"},{"location":"Nucleoplasm","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/SSH1"},"hgnc":{"alias_symbol":["KIAA1298","SSH1L"],"prev_symbol":[]},"alphafold":{"accession":"Q8WYL5","domains":[{"cath_id":"2.30.29.110","chopping":"74-226","consensus_level":"high","plddt":87.4966,"start":74,"end":226},{"cath_id":"3.90.190.10","chopping":"309-452","consensus_level":"medium","plddt":92.8225,"start":309,"end":452},{"cath_id":"1.10.10","chopping":"250-307","consensus_level":"medium","plddt":83.9683,"start":250,"end":307}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8WYL5","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8WYL5-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8WYL5-F1-predicted_aligned_error_v6.png","plddt_mean":54.41},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SSH1","jax_strain_url":"https://www.jax.org/strain/search?query=SSH1"},"sequence":{"accession":"Q8WYL5","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8WYL5.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8WYL5/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8WYL5"}},"corpus_meta":[{"pmid":"24345679","id":"PMC_24345679","title":"PLCε, PKD1, and SSH1L transduce RhoA signaling to protect mitochondria from oxidative stress in the heart.","date":"2013","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/24345679","citation_count":65,"is_preprint":false},{"pmid":"31495694","id":"PMC_31495694","title":"Mechanical Forces Regulate Cardiomyocyte Myofilament Maturation via the VCL-SSH1-CFL Axis.","date":"2019","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/31495694","citation_count":44,"is_preprint":false},{"pmid":"25684665","id":"PMC_25684665","title":"Cofilin-phosphatase slingshot-1L (SSH1L) is over-expressed in pancreatic cancer (PC) and contributes to tumor cell migration.","date":"2015","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/25684665","citation_count":43,"is_preprint":false},{"pmid":"25187968","id":"PMC_25187968","title":"The cofilin phosphatase slingshot homolog 1 (SSH1) links NOD1 signaling to actin remodeling.","date":"2014","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/25187968","citation_count":43,"is_preprint":false},{"pmid":"15459975","id":"PMC_15459975","title":"Fine mapping and identification of a candidate gene SSH1 in disseminated superficial actinic porokeratosis.","date":"2004","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/15459975","citation_count":30,"is_preprint":false},{"pmid":"30261270","id":"PMC_30261270","title":"PKCδ stimulates macropinocytosis via activation of SSH1-cofilin pathway.","date":"2018","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/30261270","citation_count":21,"is_preprint":false},{"pmid":"33044112","id":"PMC_33044112","title":"SSH1 impedes SQSTM1/p62 flux and MAPT/Tau clearance independent of CFL (cofilin) activation.","date":"2020","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/33044112","citation_count":18,"is_preprint":false},{"pmid":"33482809","id":"PMC_33482809","title":"Cofilin-1, LIMK1 and SSH1 are differentially expressed in locally advanced colorectal cancer and according to consensus molecular subtypes.","date":"2021","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/33482809","citation_count":18,"is_preprint":false},{"pmid":"32983407","id":"PMC_32983407","title":"Vascular NRP2 triggers PNET angiogenesis by activating the SSH1-cofilin axis.","date":"2020","source":"Cell & bioscience","url":"https://pubmed.ncbi.nlm.nih.gov/32983407","citation_count":14,"is_preprint":false},{"pmid":"23247370","id":"PMC_23247370","title":"The role of slingshot-1L (SSH1L) in the differentiation of human bone marrow mesenchymal stem cells into cardiomyocyte-like cells.","date":"2012","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/23247370","citation_count":13,"is_preprint":false},{"pmid":"31199753","id":"PMC_31199753","title":"In vitro import experiments with semi-intact cells suggest a role of the Sec61 paralog Ssh1 in mitochondrial biogenesis.","date":"2019","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31199753","citation_count":12,"is_preprint":false},{"pmid":"30151269","id":"PMC_30151269","title":"Overexpression of SSH1 in gastric adenocarcinoma and its correlation with clinicopathological features.","date":"2018","source":"Journal of gastrointestinal oncology","url":"https://pubmed.ncbi.nlm.nih.gov/30151269","citation_count":11,"is_preprint":false},{"pmid":"37073826","id":"PMC_37073826","title":"A systematic proximity ligation approach to studying protein-substrate specificity identifies the substrate spectrum of the Ssh1 translocon.","date":"2023","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/37073826","citation_count":7,"is_preprint":false},{"pmid":"36857607","id":"PMC_36857607","title":"SSH1 promotes progression of intrahepatic cholangiocarcinoma via p38 MAPK-CXCL8 axis.","date":"2023","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/36857607","citation_count":6,"is_preprint":false},{"pmid":"35440867","id":"PMC_35440867","title":"Ruscogenin Attenuates Lipopolysaccharide-Induced Septic Vascular Endothelial Dysfunction by Modulating the miR-146a-5p/NRP2/SSH1 Axis.","date":"2022","source":"Drug design, development and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/35440867","citation_count":5,"is_preprint":false},{"pmid":"37837551","id":"PMC_37837551","title":"Dysregulated expression of slingshot protein phosphatase 1 (SSH1) disrupts circadian rhythm and WNT signaling associated to hepatocellular carcinoma pathogenesis.","date":"2023","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/37837551","citation_count":2,"is_preprint":false},{"pmid":"30884629","id":"PMC_30884629","title":"[Expression and clinical significance of SSH1 in gastrointestinal stromal tumors].","date":"2019","source":"Zhonghua yi xue za zhi","url":"https://pubmed.ncbi.nlm.nih.gov/30884629","citation_count":1,"is_preprint":false},{"pmid":"39265451","id":"PMC_39265451","title":"Age-dependent sex differences in cofilin1 pathway (LIMK1/SSH1) and its association with AD biomarkers after chronic systemic inflammation in mice.","date":"2024","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/39265451","citation_count":1,"is_preprint":false},{"pmid":"40058575","id":"PMC_40058575","title":"Characterization of a novel virulent mycobacteriophage Kashi-SSH1 (KSSH1) depicting genus-specific broad-spectrum anti-mycobacterial activity.","date":"2025","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40058575","citation_count":1,"is_preprint":false},{"pmid":"39701356","id":"PMC_39701356","title":"Unraveling the role of SSH1 in chronic neuropathic pain: A focus on LIMK1 and Cofilin Dephosphorylation in the prefrontal cortex.","date":"2024","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/39701356","citation_count":1,"is_preprint":false},{"pmid":"40120347","id":"PMC_40120347","title":"RBMS1 promotes the proliferation of glioma cells via regulation of the c-Myc-SSH1 axis.","date":"2025","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/40120347","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.10.20.682612","title":"Exploring Size Exclusion Chromatography Columns 20 and 35 nm Pore Size Effect for Isolation of Extracellular Vesicles","date":"2025-10-20","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.20.682612","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.05.15.654186","title":"Genome landscape and genetic architecture of recombination in domestic goats (  <i>Capra Hircus</i>  )","date":"2025-05-15","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.15.654186","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.02.10.637394","title":"Loss of Cathepsin K impairs collagen biogenesis and enhances actin polymerization in trabecular meshwork","date":"2025-02-11","source":"bioRxiv","url":"https://doi.org/10.1101/2025.02.10.637394","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":14332,"output_tokens":3068,"usd":0.044508,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":10521,"output_tokens":3818,"usd":0.074027,"stage2_stop_reason":"end_turn"},"total_usd":0.118535,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2013,\n      \"finding\": \"PKD1 phosphorylates and inhibits SSH1L (SSH1) downstream of RhoA/PLCε signaling in cardiomyocytes. SSH1L inhibition prevents cofilin 2 translocation to mitochondria and blocks Bax mitochondrial translocation, thereby promoting cell survival after oxidative stress/ischemia-reperfusion injury.\",\n      \"method\": \"Genetic knockdown (SSH1L siRNA), pharmacological manipulation, western blotting for cofilin phosphorylation, mitochondrial fractionation, cardiomyocyte survival assays; epistasis established RhoA→PLCε→PKD1→SSH1L→cofilin2 pathway\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (knockdown, overexpression, genetic deletion of upstream components, fractionation, survival assay), pathway epistasis established across multiple papers and contexts\",\n      \"pmids\": [\"24345679\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"SSH1 directly interacts with NOD1 at F-actin-rich sites and is an essential component of the NOD1 innate immune signaling pathway; SSH1-mediated cofilin activation is required for NOD1-dependent NF-κB activation and cytokine release. Cytochalasin D (actin polymerization inhibitor) rescued NOD1 signaling loss upon SSH1 depletion.\",\n      \"method\": \"Genome-wide siRNA screen, co-immunoprecipitation/interaction assay showing NOD1-SSH1 interaction at F-actin sites, NF-κB reporter assay, cytokine measurement, chemical rescue with cytochalasin D\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal interaction shown, genome-wide screen validated with functional follow-up (NF-κB, cytokine, chemical rescue), single lab but multiple orthogonal methods\",\n      \"pmids\": [\"25187968\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"SSH1 (SSH1L) acts as a cofilin-1 phosphatase in pancreatic cancer cells; SSH1L knockdown increased cofilin-1 Ser3 phosphorylation (inactivation) and inhibited cell migration without affecting proliferation. Cytochalasin D abrogated migration independently of SSH1L expression.\",\n      \"method\": \"siRNA-mediated knockdown of SSH1L in PC cell lines, western blotting for phospho-cofilin-1 (Ser3), wound-healing/migration assays, cytochalasin D rescue\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KD with phosphorylation readout and functional migration phenotype, single lab\",\n      \"pmids\": [\"25684665\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Missense mutation p.Ser63Asn and frameshift mutations in SSH1 were identified in families with disseminated superficial actinic porokeratosis (DSAP), implicating SSH1 phosphatase function in epidermal cytoskeleton organization.\",\n      \"method\": \"Genome-wide linkage analysis, candidate gene sequencing, mutation identification in affected families\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — genetic mutations in human families establish functional relevance, but no direct biochemical characterization of mutant activity\",\n      \"pmids\": [\"15459975\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"In zebrafish cardiomyocytes, the mechanosensitive protein vinculin (VCL) recruits SSH1 and its effector cofilin (CFL) to regulate F-actin rearrangement and promote myofilament maturation in response to mechanical forces from heartbeat contraction.\",\n      \"method\": \"VCL interactome by mass spectrometry in contracting vs. non-contracting cardiomyocytes, co-immunoprecipitation, loss-of-function studies, live imaging of F-actin; genetic epistasis (VCL→SSH1→CFL)\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — interactome MS plus reciprocal Co-IP, genetic epistasis, functional readout (myofilament maturation), multiple orthogonal methods\",\n      \"pmids\": [\"31495694\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PKCδ activates SSH1 in macrophages, which dephosphorylates cofilin at Ser3, leading to membrane ruffle formation and macropinocytosis. SSH1 silencing blocked cofilin dephosphorylation and inhibited macropinocytosis stimulated by phorbol ester or HGF.\",\n      \"method\": \"siRNA knockdown of SSH1, western blot for phospho-cofilin, scanning electron microscopy of ruffles, flow cytometry (FITC-dextran internalization), pharmacological inhibitors\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KD with phosphorylation readout and two functional assays (EM, flow cytometry), single lab\",\n      \"pmids\": [\"30261270\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"SSH1 dephosphorylates phospho-Ser403-SQSTM1/p62, thereby impairing SQSTM1 autophagic flux and reducing clearance of phospho-MAPT/tau. This action is fully dependent on SQSTM1 Ser403 phosphorylation status and is mechanistically separable from SSH1-mediated cofilin dephosphorylation.\",\n      \"method\": \"RNAi knockdown and overexpression of SSH1, genetically encoded fluorescent reporters, defined phospho-site mutant constructs, western blotting, proximity ligation assay, experiments in cell lines, primary neurons, and mouse brains\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods (KD, OE, mutant constructs, PLA, in vivo), direct phosphorylation readout, functional separation from cofilin activity, validated in neurons and brain\",\n      \"pmids\": [\"33044112\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NRP2 activates SSH1 in endothelial cells, which in turn activates cofilin to promote F-actin polymerization, HUVEC migration, and PNET angiogenesis via a VEGF/VEGFR2-independent pathway. SSH1 silencing blocked NRP2-induced cofilin activation and cell migration.\",\n      \"method\": \"siRNA knockdown of SSH1, western blot for cofilin phosphorylation, F-actin staining, wound-healing/tube formation assays, in vivo mouse PNET model\",\n      \"journal\": \"Cell & bioscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KD with phosphorylation readout and multiple functional assays, single lab\",\n      \"pmids\": [\"32983407\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"SSH1 promotes intrahepatic cholangiocarcinoma (iCCA) cell proliferation, migration, and invasion through activation of the p38 MAPK pathway and enhanced expression of CXCL8.\",\n      \"method\": \"SSH1 overexpression and knockdown in iCCA cell lines, western blotting for p38 MAPK pathway components, CXCL8 measurement, proliferation/migration/invasion assays\",\n      \"journal\": \"Carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain- and loss-of-function with pathway readout, single lab, limited mechanistic detail in abstract\",\n      \"pmids\": [\"36857607\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CRISPR-mediated SSH1 knockout or pharmacological inhibition suppressed HCC cell viability, migration, and invasion, and downregulated WNT/β-catenin pathway components (WNT3, β-catenin, LRP5/6) and circadian clock regulators (CLOCK, BMAL1), while upregulating CFL-1/2 and CRY1.\",\n      \"method\": \"CRISPR SSH1 knockout, pharmacological inhibition (Sennoside A), cell viability/migration/invasion assays, western blotting, in vivo mouse tumor model\",\n      \"journal\": \"Aging\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR KO with multiple functional and pathway readouts, in vivo validation, single lab\",\n      \"pmids\": [\"37837551\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"SSH1 modulates neuropathic pain and neuronal health in the medial prefrontal cortex by dephosphorylating cofilin and LIMK1; co-immunoprecipitation demonstrated interaction between SSH1 and LIMK1.\",\n      \"method\": \"Lentiviral overexpression and knockdown of SSH1 in mouse mPFC, behavioral assays, western blotting for p-cofilin and p-LIMK1, co-immunoprecipitation, immunofluorescence\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo gain/loss-of-function with phosphorylation and behavioral readouts plus Co-IP interaction, single lab\",\n      \"pmids\": [\"39701356\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"RBMS1 promotes glioma cell proliferation through a c-Myc-SSH1 axis: RBMS1 induces c-Myc binding to SSH1 promoters, increasing SSH1 expression, which in turn supports proliferative behavior.\",\n      \"method\": \"Patient datasets, glioma cell lines, mouse xenograft models, chromatin immunoprecipitation (c-Myc binding to SSH1 promoter), knockdown/overexpression experiments, proliferation assays\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transcriptional regulation mechanism established by ChIP and functional assays, single lab\",\n      \"pmids\": [\"40120347\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SSH1 (Slingshot Homolog 1) is a protein phosphatase that canonically dephosphorylates and reactivates cofilin (Ser3) to promote actin dynamics and cell migration, but also dephosphorylates SQSTM1/p62 at Ser403 (independently of cofilin) to impair autophagic cargo clearance including phospho-tau; it is regulated by upstream kinases (PKD1 phosphorylates and inhibits it; PKCδ activates it), physically interacts with NOD1 at actin-rich sites to mediate innate immune NF-κB signaling, and is recruited by vinculin downstream of mechanical forces to coordinate myofilament maturation via the VCL-SSH1-CFL axis.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SSH1 (Slingshot Homolog 1) is a protein phosphatase that governs actin cytoskeletal dynamics by dephosphorylating cofilin at Ser3, reactivating it to drive F-actin remodeling across diverse cell types and physiological processes including cell migration, macropinocytosis, angiogenesis, and myofilament maturation [#2, #5, #7]. Its cofilin-directed activity is embedded in defined signaling axes: it is activated downstream of PKC\\u03b4 in macrophages to drive membrane ruffling and macropinocytosis [#5] and downstream of NRP2 in endothelial cells to promote migration and angiogenesis [#7], whereas PKD1 phosphorylates and inhibits SSH1 downstream of RhoA/PLC\\u03b5, an event that controls cofilin-2 and Bax mitochondrial translocation and thereby cardiomyocyte survival [#0]. SSH1 also operates within mechanotransduction, where vinculin recruits SSH1 and cofilin to remodel F-actin and promote myofilament maturation in response to contractile force [#4], and it acts as an essential component of NOD1 innate immune signaling, interacting directly with NOD1 at F-actin-rich sites to enable NF-\\u03baB activation and cytokine release [#1]. Beyond cofilin, SSH1 dephosphorylates SQSTM1/p62 at Ser403 in a manner mechanistically separable from its cofilin activity, impairing autophagic flux and reducing clearance of phospho-tau in neurons and brain [#6]. SSH1 also dephosphorylates LIMK1 and modulates neuropathic pain in the prefrontal cortex [#10], and it is co-opted in multiple cancers \\u2014 supporting proliferation and invasion via p38 MAPK/CXCL8, WNT/\\u03b2-catenin, and a c-Myc transcriptional axis [#8, #9, #11]. Mutations in SSH1 are linked to disseminated superficial actinic porokeratosis, connecting its phosphatase function to epidermal cytoskeletal organization [#3].\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Established the first human disease link for SSH1, indicating its phosphatase function is relevant to epidermal cytoskeletal integrity in vivo.\",\n      \"evidence\": \"Linkage analysis and candidate gene sequencing identifying missense and frameshift mutations in DSAP families\",\n      \"pmids\": [\"15459975\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No biochemical characterization of mutant phosphatase activity\", \"Mechanism connecting loss of SSH1 to porokeratosis pathology not defined\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Defined an upstream inhibitory regulator of SSH1, showing that PKD1 phosphorylation suppresses SSH1 to control cofilin-2/Bax mitochondrial translocation and cell survival.\",\n      \"evidence\": \"siRNA knockdown, pharmacology, mitochondrial fractionation and survival assays in cardiomyocytes establishing RhoA\\u2192PLC\\u03b5\\u2192PKD1\\u2192SSH1\\u2192cofilin2 epistasis\",\n      \"pmids\": [\"24345679\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct phosphatase activity on the mitochondrial pool not biochemically reconstituted\", \"How cofilin-2 translocation triggers Bax import is unresolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Revealed a non-canonical role for SSH1 in innate immunity, placing its actin-regulatory activity upstream of NOD1-dependent NF-\\u03baB signaling.\",\n      \"evidence\": \"Genome-wide siRNA screen, NOD1-SSH1 Co-IP at F-actin sites, NF-\\u03baB reporter, cytokine measurement, and cytochalasin D rescue\",\n      \"pmids\": [\"25187968\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SSH1 phosphatase activity is required versus a scaffolding role not fully separated\", \"Direct binding interface with NOD1 not mapped\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Confirmed SSH1 as a cofilin-1 Ser3 phosphatase driving cancer cell migration independently of proliferation.\",\n      \"evidence\": \"siRNA knockdown, phospho-cofilin western blot, wound-healing assays and cytochalasin D rescue in pancreatic cancer cells\",\n      \"pmids\": [\"25684665\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single cancer context\", \"Upstream activators in this setting not identified\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identified PKC\\u03b4 as an activating upstream kinase coupling SSH1/cofilin activity to membrane ruffling and macropinocytosis.\",\n      \"evidence\": \"siRNA knockdown, phospho-cofilin western blot, scanning EM of ruffles, and FITC-dextran flow cytometry in macrophages\",\n      \"pmids\": [\"30261270\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether PKC\\u03b4 acts directly on SSH1 not biochemically shown\", \"Single lab\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Positioned SSH1 within mechanotransduction, showing vinculin recruits it to convert contractile force into actin remodeling during myofilament maturation.\",\n      \"evidence\": \"VCL interactome MS in contracting vs non-contracting cardiomyocytes, reciprocal Co-IP, loss-of-function and live F-actin imaging with VCL\\u2192SSH1\\u2192CFL epistasis in zebrafish\",\n      \"pmids\": [\"31495694\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct VCL-SSH1 binding interface not mapped\", \"How force modulates SSH1 catalytic activity unknown\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Established a cofilin-independent substrate, showing SSH1 dephosphorylates SQSTM1/p62 Ser403 to impair autophagy and phospho-tau clearance.\",\n      \"evidence\": \"RNAi/overexpression, phospho-site mutant constructs, proximity ligation assay, and validation in cell lines, primary neurons and mouse brain\",\n      \"pmids\": [\"33044112\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for substrate selection between p62 and cofilin not defined\", \"Regulation of SSH1 activity toward p62 in neurodegeneration unresolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Added NRP2 as an activator of SSH1 driving VEGF/VEGFR2-independent endothelial migration and tumor angiogenesis.\",\n      \"evidence\": \"siRNA knockdown, phospho-cofilin western blot, F-actin staining, tube formation assays and in vivo PNET model\",\n      \"pmids\": [\"32983407\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct NRP2-SSH1 coupling mechanism not shown\", \"Single lab\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Extended SSH1's pro-tumorigenic role to additional cancers via distinct downstream pathways (p38 MAPK/CXCL8 and WNT/\\u03b2-catenin plus circadian regulators).\",\n      \"evidence\": \"Gain/loss-of-function with pathway western blots, CRISPR knockout, pharmacological inhibition, and in vivo tumor models in iCCA and HCC\",\n      \"pmids\": [\"36857607\", \"37837551\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether phosphatase catalytic activity links SSH1 to these pathways not established\", \"Connection to canonical cofilin axis in these contexts unclear\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Showed SSH1 acts on LIMK1 in addition to cofilin in the prefrontal cortex to modulate neuropathic pain and neuronal health.\",\n      \"evidence\": \"Lentiviral overexpression/knockdown in mouse mPFC, behavioral assays, phospho-cofilin/phospho-LIMK1 western blots and SSH1-LIMK1 Co-IP\",\n      \"pmids\": [\"39701356\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct dephosphorylation of LIMK1 versus indirect effect not resolved\", \"Single lab\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Defined transcriptional control of SSH1, showing an RBMS1/c-Myc axis drives SSH1 expression to support glioma proliferation.\",\n      \"evidence\": \"ChIP for c-Myc binding to the SSH1 promoter, knockdown/overexpression, proliferation assays and xenografts\",\n      \"pmids\": [\"40120347\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Downstream SSH1 effector in glioma not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How SSH1 selects between its substrates (cofilin, SQSTM1/p62, LIMK1) and how distinct upstream inputs are integrated to direct context-specific outputs remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of substrate recognition\", \"Mechanism integrating activating (PKC\\u03b4, NRP2) and inhibitory (PKD1) inputs unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [2, 5, 6]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [2, 5, 6, 10]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [1, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [1, 4]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [1]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 5, 7]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"CFL1\", \"NOD1\", \"VCL\", \"LIMK1\", \"PKD1\", \"PRKCD\", \"NRP2\", \"SQSTM1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}